A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer.
STAMPEDE2
Add-Aspirin
A phase III double-blind, placebo-controlled, randomised trial assessing the effects of aspirin on disease recurrence and survival after primary therapy in common non-metastatic solid tumours
ARCHERY
A prospective observational study of artificial intelligence based radiotherapy treatment planning for cervical, head and neck and prostate cancer
DADSPORT
Duration of androgen suppression with post-operative radiotherapy (DADSPORT): A meta-analysis of aggregate data
REFINE
REduced Frequency ImmuNE checkpoint inhibition in cancers
STOPCAP M1 Programme
Speeding up the evaluation of therapies for metastatic, hormone-sensitive prostate cancer
UKLWC
UKCTOCS Longitudinal Women’s Cohort
